Martin Archer K
Department of Anesthesiology, Mayo Clinic College of Medicine, Florida, USA.
Rom J Anaesth Intensive Care. 2016 Apr;23(1):77-81. doi: 10.21454/rjaic.7518.231.sfb.
In our 21 century world, human-robotic interactions are far more complicated than Asimov predicted in 1942. The future of human-robotic interactions includes human-robotic machine hybrids with an integrated physiology, working together to achieve an enhanced level of baseline human physiological performance. This achievement can be described as a biological Singularity. I argue that this time of Singularity cannot be met by current biological technologies, and that human-robotic physiology must be integrated for the Singularity to occur. In order to conquer the challenges we face regarding human-robotic physiology, we first need to identify a working model in today's world. Once identified, this model can form the basis for the study, creation, expansion, and optimization of human-robotic hybrid physiology. In this paper, I present and defend the line of argument that currently this kind of model (proposed to be named "IshBot") can best be studied in ventricular assist devices - VAD.
在我们这个21世纪的世界里,人类与机器人的互动远比阿西莫夫在1942年所预测的要复杂得多。人类与机器人互动的未来包括具有整合生理学的人机混合体,它们共同协作以实现人类生理基线表现的提升。这一成就可被描述为一种生物学奇点。我认为,当前的生物技术无法实现这一奇点时刻,并且必须整合人机生理学才能实现奇点。为了应对我们在人机生理学方面面临的挑战,我们首先需要在当今世界确定一个可行的模型。一旦确定,这个模型就能为研究、创造、扩展和优化人机混合生理学奠定基础。在本文中,我提出并捍卫这样一种论点,即目前这种模型(提议命名为“IshBot”)在心室辅助装置(VAD)中最适合进行研究。